A new family of regulators of calcineurin (RCANs)

Progress in Biochemistry and Biophysics

Volumn 37, Issue 1, 2010, Pages 22-28

  Tu, Ling Hui ^a   Liu, Hai Peng ^a   Luo, Jing ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Calcineurin; Rcan gene; Rcans; Tau

Indexed keywords

EID: 77952079890     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2009.00287     Document Type: Review

References (65)

1. Davies K J A, Ermak G, Rothermal B A, et al. Renaming the DSCR1/A dapt78 gene family as RCAN: regulators of calcineurin. FASEB J, 2007, 21(12): 3023-3028
2. Bult C J, Eppig J T, Kadin J A, et al. The mouse genome database (MGD): mouse biology and model systems. Nucleic Acids Res, 2008, 36(Supplement 1): D724-D728
3. Facchin F, Canaider S, Vitale L, et al. Identification and analysis of human RCAN3 (DSCR1L2) mRNA and protein isoforms. Gene, 2008, 407(1-2): 159-168 (Pubitemid 350251664)
4. Canellada A, Ramirez B G, Minami T, et al. Calcium/calcineurin signaling in primary cortical astrocyte cultures: Rcan1-4 and cyclooxygenase-2 as NFAT target genes. Glia, 2008, 56(7): 709-722
5. Cano E, Canellada A, Minami T, et al. Depolarization of neural cells induces transcription of the down syndrome critical region 1 isoform 4 via a calcineurin/nuclear factor of activated T cells-dependent pathway. J Biol Chem, 2005, 280 (33): 29435-29443 (Pubitemid 41177016)
6. Fuentes J J, Pritchard M A, Planas A M, et al. A new human gene from the down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Hum Mol Genet, 1995, 4(10): 1935-1944
7. Harris C D, Ermak G, Davies K J. RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients. FEBS J, 2007, 274(7): 1715-1724 (Pubitemid 46426906)
8. Crawford D R, Leahy K P, Abramova N, et al. Hamster adapt78 mRNA is a down syndrome critical region homologue that is inducible by oxidative stress. Arch Biochem Biophys, 1997, 342(1): 6-12
9. Lin H Y, Michtalik H J, Zhang S, et al. Oxidative and calcium stress regulate DSCR1 (Adapt78/MCIP1) protein. Free Radic Biol Med, 2003, 35(5): 528-539 (Pubitemid 37289162)
10. Ermak G, Cheadle C, Becker K G, et al. DSCR1(Adapt78) modulates expression of SOD1. FASEB J, 2004, 18(1): 62-69
11. Ermak G, Harris C D, Davies K J A. The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress. FASEB J, 2002, 16(8): 814-824
12. Leahy K P, Crawford D R. Adapt78 protects cells against stress damage and suppresses cell growth. Arch Biochem Biophys, 2000, 379(2): 221-228
13. Michtalik H J, Narayan A V, Bhatt N, et al. Multiple oxidative stress-response members of the Adapt78 family. Free Radic. Biol. Med, 2004, 37(4): 454-462
14. Fuentes J J, Genesca L, Kingsbury T J, et al. DSCR1, overexpressed in down syndrome, is an inhibitor of calcineurin mediated signaling pathways. Hum Mol Genet, 2000, 9(11): 1681-1690 (Pubitemid 30427005)
15. Kingsbury T J, Cunningham K W. A conserved family of calcineurin regulators. Genes & Dev, 2000, 14(13): 1595-1604
16. Rothermel B, Vega R B, Yang J, et al. A protein encoded within the down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem, 2000, 275(12): 8719-8725 (Pubitemid 30180224)
17. Strippoli P, Lenzi L, Petrini M, et al. A new gene family including DSCR1 (down syndrome candidate region 1) and ZAKI-4: characterization from yeast to human and identification of DSCR1-like 2, a novel human member (DSCR1L2). Genomics, 2000, 64(3): 252-263 (Pubitemid 30212626)
18. Yang J, Rothermel B, Vega R B. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res, 2000, 87(12): E61-E68
19. Hogan P G, Chen L, Nardone J, et al. Transcriptional regulation by calcium, calcineurin, and NFAT. Gene Dev, 2003, 17(18): 2205-2232 (Pubitemid 37128637)
20. Rao A. Signaling to gene expression: calcium, calcineurin and NFAT. Nat Immunol, 2009, 10(1): 3-5
21. Rodriguez A, Martinez-Martinez S, Lopez-Maderuelo M D, et al. A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants. Mol Cell, 2009, 33(5): 616-626
22. Rusnak F, Mertz P. Calcineurin: form and function. Physiol Rev, 2000, 80(4): 1483-1521
23. Aubareda A, Mulero M C, Perez-Riba M. Functional characterization of the calcipressin 1 motif that suppresses calcineurin-mediated NFAT-dependent cytokine gene expression in human T cells. Cell Signal, 2006, 18(9): 1430-1438 (Pubitemid 43832079)
24. Chan B, Greenan G, McKeon F, et al. Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo. Proc Natl Acad Sci USA, 2005, 102 (37): 13075-13080 (Pubitemid 41324981)
25. Genesca L, Aubareda A, Fuentes J J, et al. Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin and decreases calcipressin half-life. Biochem J, 2003, 374 (pt 2): 567-575 (Pubitemid 37094118)
26. Vega R B, Yang J, Rothermel B A, et al. Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J Biol Chem, 2002, 277(33): 30401-30407
27. Pinchai N, Zachary Perfect B, Juwadi P R, et al. Aspergillus fumigatus calcipressin CbpA is involved in hyphal growth and calcium homeostasis. Eukaryot Cell, 2009, 8(4): 511-519
28. Martínez-Martínez S, Genescà L, Rodríguez A, et al. The RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators. Proc Natl Acad Sci USA, 2009, 106(15): 6117-6122
29. Naesens M, Kuypers D R J, Sarwal M, et al. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol, 2009, 4(2): 481-508
30. Carme Mulero M, Aubareda A, Orzáez M, et al. Inhibiting the calcineurin-NFAT (nuclear factor of activated T cells) signaling pathway with a regulator of calcineurin-derived peptide without affecting general calcineurin phosphatase activity. J Biol Chem, 2009, 284(14): 9394-9401
31. Vega R B, Rothermel B A, Weinheimer C J, et al. Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc Natl Acad Sci USA, 2003, 100(2): 669-674
32. Sanna B, Brandt E B, Kaiser R A, et al. Modulatory calcineurininteracting proteins 1 and 2 function as calcineurin facilitators in vivo. Proc Natl Acad Sci USA, 2006, 103(19): 7327-7332 (Pubitemid 43727832)
33. Fox D S, Heitman J. Calcineurin-binding protein Cbpl directs the specificity of calcineurin-dependent hyphal elongation during mating in Cryptococcus neoformans. Eukaryot Cell, 2005, 4(9): 1526-1538 (Pubitemid 41339108)
34. Abbasi S, Lee J D, Su B, et al. Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin- interacting protein 1. J Biol Chem, 2006, 281(12): 7717-7726 (Pubitemid 43847385)
35. Arron J R, Winslow M M, Polleri A, et al. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature, 2006, 441(7093): 595-600 (Pubitemid 43927286)
36. Graef I A, Crabtree G R. Bursting into the nucleus. Sci Signal, 2008, 1(51): pe54
37. Norenberg M D, Rao K V. The mitochondrial permeability transition in neurologic disease. Neurochem Int, 2007, 50(7-8): 983-997 (Pubitemid 46962816)
38. Ermak G, Harris C D, Battocchio D, et al. RCAN1 (DSCR1 or Adapt78) stimulates expression of GSK-3beta. FEBS J, 2006, 273(10): 2100-2109
39. Hilioti Z, Gallagher D A, Low-Nam S T, et al. GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNs. Gene Dev, 2004, 18(1): 35-47 (Pubitemid 38090686)
40. Liu Q, Busby J C, Molkentin J D. Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Nat Cell Biol, 2009, 11(2): 154-161
41. Liu H, Wang P, Song W H, et al. Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways. FASEB J, 2009, 23(10): 3383-3392
42. Mehta S, Li H M, Hogan P G, et al. Domain architecture of the regulators of calcineurin (RCANs) and identification of a divergent RCAN in Yeast. Mol Cell Biol, 2009, 29(10): 2777-2793
43. Kayyali U S, Zhang W, Yee A G, et al. Cytoskeletal change in the brains of mice lacking calcineurin Act. J Neurochem, 1997, 68(4): 1668-1678
44. Yu D Y, Luo J, Bu F, et al. Inhibition of calcineurin by infusion of CsA causes hyperphosphorylation of tau, accompanied by abnormal behavior in mice. Biological Chemistry, 2006, 387(7): 977-983
45. Yu D Y, Luo J, Bu F, et al. Effects of CsA, FK506 and rapamycin on calcineurin activity in mouse brain. IUBMB life, 2006, 58(7): 429-433
46. Wei Q, Holzer M, Brueckner M K, et al. Dephosphorylation of tau protein by calcineurin (PP2B) led to neural living cells. Cell Mol Neurobiol, 2002, 22(1): 13-24 (Pubitemid 34579405)
47. Ermak G, Morgan T E, Davies K J. Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease. J Biol Chem, 2001, 276(42): 38787-38794 (Pubitemid 37371240)
48. Harris C D, Ermak G, Davies K J A. Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease. Cell Mol Life Sci, 2005, 62(21): 2477-2486
49. Cook C N, Hejna M J, Magnuson D J, et al. Expression of calcipressin 1, an inhibitor of the phosphatase calcineurin, is altered with aging and Alzheimer's disease. J Alzheimers Dis, 2005, 8(1): 63-73
50. Hoeffer C A, Dey A, Sachan N, et al. The down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling. J Neurosci, 2007, 27(48): 13161-13172
51. Chang K T, Shi Y J, Min K T. The Drosophila homolog of Down's syndrome critical region 1 gene regulates learning: implications for mental retardation. Proc Natl Acad Sci USA, 2003, 100 (26): 15794-15799
52. Ma H, Xiong H, Liu T, et al. Aggregate formation and synaptic abnormality induced by DSCR1. J Neurochem, 2004, 88 (6): 1485-1496 (Pubitemid 38366925)
53. Keating D J, Dubach D, Zanin M P, et al. DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for down syndrome and Alzheimer's disease. Hum Mol Genet, 2008, 17(7): 1020-1030
54. Portal S, Serra S A, Huch M, et al. RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: a potential pathogenic process in neurodegeneration. Hum Mol Genet, 2007, 16(9): 1039-1050 (Pubitemid 47062725)
55. Stie J, Fox D. Calcineurin regulation in Fungi and beyond. Eukaryot Cell, 2008, 7(2): 177-186
56. 2+-operated transcriptional networks: molecular mechanisms and in vivo models. Physiol Rev, 2008, 88(2): 421-449
57. Ermak G, Hench K J, Chang K T, et al. Regulator of calcineurin (RCAN1-1L) is deficient in huntington disease and protective against mutant huntingtin toxicity in vitro. J Biol Chem, 2009, 284 (18): 11845-11853
58. εRI-mediated signaling and mast cell function. J Exp Med, 2009, 206(1): 195-207
59. Li T Z, Xiang B Q. Prog Biochem Biophys, 2009, 36(2): 133-142
60. Wang B J,Wei Q. Sei in China Serices C, 2008, 38(7): 591-598
61. Yan L J, Yu C J, Zhang L F, et al. Sei in China Serices C, 2000, 30 (2): 177-182
62. Luo J, Ma J, Yu D Y, et al. Infusion of FK506, a specific inhibitor of calcineurin, induces potent tau hyperphosphorylation in mouse brain. Brain Res Bull, 2008, 76(5): 464-468
63. Luo J, Yin J H, Wei Q. The effect of a calcineurin activator, extracted from Chinese herbal medicine on memory and immunity in mice. Pharmacol Biochem Behav, 2003, 75(4): 749-754 (Pubitemid 37289459)
64. Tong L, Song Y, Zhang S D, et al. Calmodulin-dependent activation of calcineurin by chlorogenic Acid. IUBMB Life, 2007, 59(6): 402-407
65. Wu H Z, Luo J, Yin Y X, et al. Effects of chlorogenic acid, an active compound activating calcineurin, purified from Flos lonicerae on macrophage. Acta Pharmacol Sin, 2004, 25 (12): 1685-1689